Evidence map›Paper›PMID 32941183›Full record

ArticleJCI insight2020

Renal proximal tubular NEMO plays a critical role in ischemic acute kidney injury.

Sang Jun Han, Ryan M Williams, Mihwa Kim, Daniel A Heller, Vivette D'Agati, Marc Schmidt-Supprian, H Thomas Lee

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. NEMO (IKKγ) citrullination in microglia promotes neuroinflammation in the post-ischemic brain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Cell and gene therapy for kidney disease.Nature reviews. Nephrology · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Novel Drug Delivery Technologies and Targets for Renal Disease.Hypertension (Dallas, Tex. : 1979) · 2022
    Review
  11. Article
  12. Recent Approaches to Targeting Canonical NFJournal of the American Society of Nephrology : JASN · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sang Jun HanDepartment of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
Ryan M WilliamsDepartment of Biomedical Engineering, City College of New York, New York, New York, USA.
Mihwa KimDepartment of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
Daniel A HellerDepartment of Molecular Pharmacology & Chemistry, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Vivette D'AgatiDepartment of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
Marc Schmidt-SupprianInstitute of Experimental Hematology, School of Medicine, Technical University Munich, Munich, Germany.
H Thomas LeeDepartment of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
Columbia University · USCity College of New York · USMemorial Sloan Kettering Cancer Center · USTechnical University of Munich · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Paneth cells and acute kidney injuryR01DK109544 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEE, H. THOMAS · 2017 to 2021
$1.8M
Peptidylarginine deiminase-4 and acute kidney injuryR01DK115694 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEE, H. THOMAS · 2017 to 2021
$1.6M
Renal tubule-specific nanotherapeutics for acute kidney injuryR01DK114321 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN, JAIMES, EDGAR A · 2018 to 2020
$796k
NCI NIH HHS P30 CA008748NIDDK NIH HHS R01 DK109544NIDDK NIH HHS R01 DK114321NIDDK NIH HHS R01 DK115694
6 · The paper itself

Abstract

We determined that renal proximal tubular (PT) NF-κB essential modulator (NEMO) plays a direct and critical role in ischemic acute kidney injury (AKI) using mice lacking renal PT NEMO and by targeted renal PT NEMO inhibition with mesoscale nanoparticle-encapsulated NEMO binding peptide (NBP MNP). We subjected renal PT NEMO-deficient mice, WT mice, and C57BL/6 mice to sham surgery or 30 minutes of renal ischemia and reperfusion (IR). C57BL/6 mice received NBP MNP or empty MNP before renal IR injury. Mice treated with NBP MNP and mice deficient in renal PT NEMO were protected against ischemic AKI, having decreased renal tubular necrosis, inflammation, and apoptosis compared with control MNP-treated or WT mice, respectively. Recombinant peptidylarginine deiminase type 4 (rPAD4) targeted kidney PT NEMO to exacerbate ischemic AKI in that exogenous rPAD4 exacerbated renal IR injury in WT mice but not in renal PT NEMO-deficient mice. Furthermore, rPAD4 upregulated proinflammatory cytokine mRNA and NF-κB activation in freshly isolated renal proximal tubules from WT mice but not from PT NEMO-deficient mice. Taken together, our studies suggest that renal PT NEMO plays a critical role in ischemic AKI by promoting renal tubular inflammation, apoptosis, and necrosis.

Indexed as

Gene Expression RegulationAcute Kidney InjuryAnimalsApoptosisCarrier ProteinsChemokine CCL2Chemokine CXCL2Drug CompoundingIntercellular Adhesion Molecule-1Interleukin-6Intracellular Signaling Peptides and ProteinsKidney Tubules, ProximalMaleMiceMice, Inbred C57BLMice, KnockoutCarrier ProteinsCcl2 protein, mouseChemokine CCL2Chemokine CXCL2Cxcl2 protein, mouseIcam1 protein, mouseIntercellular Adhesion Molecule-1Interleukin-6interleukin-6, mouseIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BPeptidespeptidylarginine deiminase 4, mouseProtein-Arginine Deiminase Type 4Tumor Necrosis Factor-alphaInflammationPharmacology

Identifiers

PMID32941183
PMCPMC7566738
OpenAlexW3087207832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.